The Impact of the Initial Clinical Presentation of Bladder Cancer on Histopathological and Morphological Tumor Characteristics.
asymptomatic diseases
early detection of cancer
hematuria
lower urinary tract symptoms
urinary bladder neoplasms
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Jun 2023
25 Jun 2023
Historique:
received:
04
06
2023
revised:
19
06
2023
accepted:
23
06
2023
medline:
14
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
This study investigated the impact of the initial clinical presentation of bladder cancer on tumor characteristics. A cross-sectional, retrospective study was performed, and it involved 515 patients who underwent transurethral bladder cancer resection at the University Hospital Center Split between April 2019 and April 2023, excluding recurrent cases. The association between symptomatic versus asymptomatic presentation and bladder cancer characteristics was analyzed. A subgroup analysis compared tumor characteristics between patients with gross and microscopic hematuria. Multiple regression analyses revealed a significant association between symptomatic presentation and the detection of high-grade bladder cancer (OR 3.43, 95% CI 2.22-5.29,
Identifiants
pubmed: 37445294
pii: jcm12134259
doi: 10.3390/jcm12134259
pmc: PMC10342402
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Urol. 1989 Feb;141(2):350-5
pubmed: 2492350
Urol Int. 2022;106(8):798-805
pubmed: 35152219
PLoS One. 2015 Apr 07;10(4):e0123617
pubmed: 25849552
Front Oncol. 2021 Jun 16;11:690324
pubmed: 34222019
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3370-3377
pubmed: 29917188
Aust Fam Physician. 2011 Apr;40(4):209-13
pubmed: 21597531
Int J Biol Markers. 2020 Jun;35(2):29-39
pubmed: 32312147
Int J Urol. 2017 Oct;24(10):730-734
pubmed: 28543959
Eur Urol. 2021 Apr;79(4):480-488
pubmed: 33419683
BJU Int. 2016 May;117(5):783-6
pubmed: 26435378
Exp Ther Med. 2019 Nov;18(5):3405-3414
pubmed: 31602215
Am J Surg Pathol. 2020 Jul;44(7):e30-e46
pubmed: 32091435
Cancers (Basel). 2023 Jan 21;15(3):
pubmed: 36765629
J R Coll Surg Edinb. 2000 Oct;45(5):291-5
pubmed: 11077776
Urol Int. 2011;87(3):319-24
pubmed: 21849760
Urology. 2005 Dec;66(6 Suppl 1):4-34
pubmed: 16399414
Urol Oncol. 2015 Feb;33(2):65.e19-25
pubmed: 25044253
Public Health Genomics. 2019;22(1-2):8-15
pubmed: 31330522
Urol Int. 2022;106(8):791-797
pubmed: 34352796
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
BMC Urol. 2022 Dec 27;22(1):212
pubmed: 36575440
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
J Urol. 2020 Oct;204(4):778-786
pubmed: 32698717
Radiol Clin North Am. 2007 Jan;45(1):183-205
pubmed: 17157629
Diagn Interv Radiol. 2018 Sep;24(5):316-320
pubmed: 30211685
Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7
pubmed: 16442208
Actas Urol Esp (Engl Ed). 2023 Jun;47(5):296-302
pubmed: 36443223
Urol Oncol. 2010 Sep-Oct;28(5):500-3
pubmed: 19097811
Eur Urol. 2016 Jul;70(1):106-119
pubmed: 26996659
Jpn J Clin Oncol. 2016 Oct;46(10):964-967
pubmed: 27511986
Cancer Control. 2002 Jul-Aug;9(4):284-92
pubmed: 12228754